Radar · drug · signal
Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use ORecall or enforcement action
Complete coverage checks before an early-window claim.
Statistical status
No screen yetReceipt-date counts have not been screened.
Evidence score
—Research priority weight, not a probability of causation or recovery.
Missing: none recorded
Competition
unknownObserved in monitored channels only. Unknown is not zero.
Coverage unknown. Early-window label is blocked.
What changed
Qualitative review · notice
Enforcement report. This is a product action, not an injury count. Defective Delivery System: Possibility of no medication in the prefilled pen.
10/09/2026 · A recall may not involve the injury later investigated.
Read the source
Report trends
Receipt dates are the reporting screen. Event dates are a separate, lag-sensitive series. They are not added together.
| Basis | Window | Covered days | Reports | Expected | Fold | Complete |
|---|
Related filings
Unknown. Court and RECAP collectors are not in this release. Do not read a blank docket as zero lawsuits.
Observed competitors
- No firm pages or ad notes. Competition stays unknown until the panel records one.